You are here

Lipids & Metabolic


When third-grader Ava Rao was diagnosed with type 1 diabetes, it changed life for her whole family. Now a high school freshman, Ava and her dad, cardiologist Sunil V. Rao, MD, share their perspectives on the disease and hopes for the future. 

Following the White House physician’s Jan. 16 assertion that President Donald Trump is in “excellent health,” a few national news outlets published stories questioning that claim.

The unrelenting growth of diabetes around the world is prompting cardiologists to rethink how they treat and manage a challenging patient population, even as an emerging class of cardio-protective diabetes drugs is setting the stage for transformation.

Black men and women who smoke more than one pack of cigarettes a day could be as much as 79 percent more likely to develop diabetes mellitus than those who have never smoked, according to a study published this month in the Journal of the American Heart Association.

Exposure to a Western diet high in refined sugars, salt and saturated fat can have a permanent impact on the body’s immune system even if the diet is later changed, new research published in Cell suggests.


Recent Headlines

Research links socioeconomic stress to metabolic syndrome in black youth

Socioeconomic stress could have a major impact on black young adults’ heart health, according to a new study published in the Journal of the American Heart Association.

Metabolically healthy obese individuals still at increased risk for heart disease

After spending nearly six years researching the relationship between metabolically healthy obesity and risk of cardiovascular disease, a team of U.K. doctors are suggesting that even “healthy” obese individuals are more prone to develop heart issues.

Children exposed to toxic dust after 9/11 show signs of heart disease

Children exposed to toxic dust after the attack on New York's World Trade Centers in 2001 are showing early signs of cardiovascular risks, a study suggests.

'Good' cholesterol not so great in extreme cases

Apparently, it’s possible to have too much of a good thing. At least that’s what researchers are suggesting about high-density lipoprotein (HDL) cholesterol, widely known as the “good” type of cholesterol.

Diabetes drug gains FDA indication for CV benefit

The diabetes drug liraglutide (Victoza) secured an indication from the FDA to reduce the risk of major adverse cardiovascular (CV) events in adults with Type 2 diabetes and established cardiovascular disease, Novo Nordisk announced Aug. 25.

Statin therapy ineffective in patients with advanced kidney disease

Patients with advanced renal dysfunction received no significant benefit from statin therapy following acute MI in a study of 861 individuals.

Study finds similar cost value of CAC testing, widespread statin treatment

When it comes to choosing whether to initiate statin treatment, similar clinical and economic consequences result if clinicians follow current guidelines or use coronary artery calcium (CAC) testing to guide that decision, according to new research.

Oral treatment enough to lower cholesterol in most patients

Nearly nine in 10 patients with atherosclerotic cardiovascular disease (ASCVD) could improve their cholesterol levels with oral-only treatment, according to a new study.

Race, prehypertension among midlife risk factors for dementia

Potentially modifiable midlife vascular risk factors could be associated with dementia later in life, according to a study.

AAP advises pediatricians to examine cardiometabolic risk factors when treating child obesity

In an effort to address the growing number of overweight and obese children in the U.S., the American Academy of Pediatrics, (AAP) is now recommending that pediatricians turn their attention to cardiometabolic risk factors associated with the condition.